retatrutide trial weight loss A new weight-loss drug called is generating excitement after clinical participants lost an average of 30% of their body weight, results that rival or even exceed weight-loss surgery. Researchers also Phase-3-Retatrutide-trial-sees-participants-achieve-up-to-30-weight-loss

Liu T-h, Chen M-h, Zhang C-y, Xie T, Zhang S, Hao H, et al

Fat grafting provides long-lasting results

Glucagon-like peptide-1 (GLP-1) receptor agonists have emerged as a novel and effective solution, having initially been approved and marketed for glycemic control in type 2 diabetes

Who Is Left Out The Bridge is a Part D demonstration, so some beneficiaries cannot use it directly

If you want quicker results, injectable semaglutide may be a more effective option

The researchers identified 580 patients who had previously used GLP-1s, examining results from 322 patients with ulcerative colitis and 258 patients with Crohns disease compared with a control group of patients with IBD who did not use GLP-1s